Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOD2 genotype-guided norfloxacin prophylaxis in cirrhosis with ascites
DRKS00005616Phase 3Completed
- Sponsor
- Saarland University
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis and ascites comparing Norfloxacin prophylaxis with Placebo (2 arms). Started Jan 2014; status: completed.
02
Drugs
norfloxacin
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on DRKS00005616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005616.